This clinical trial focuses on studying the treatment of breast cancer using several commonly used medications. The medications being studied include Docetaxel, Cyclophosphamide, Epirubicin, Paclitaxel, and Doxorubicin. These drugs are often used in the routine treatment of breast cancer, and the study aims to monitor their effects to better understand how they work and how they might be adjusted for individual patients in the future.
The purpose of the study is to measure the levels of these drugs in the body and to see how they relate to side effects and treatment outcomes. This information could help doctors adjust doses for future patients to avoid giving too much or too little of the medication. The study will involve monitoring patients who are receiving these drugs as part of their breast cancer treatment. The researchers will look for patterns between the amount of drug exposure and various health effects, such as blood health, liver function, heart health, and overall quality of life.
Throughout the study, participants will receive their usual breast cancer treatments, and the researchers will collect information on how the drugs affect them. The study will also explore whether certain genetic factors might influence how patients process these drugs, which could help identify those at risk of receiving too much or too little medication. The ultimate goal is to improve treatment by tailoring drug doses to each patient’s needs, potentially leading to better outcomes and fewer side effects.
Sweden 
